A Phase 2 Study of Stopping Trastuzumab - Outcomes in Patients with HER2+ Metastatic Breast Cancer
Clinical Trial Grant
Awarded By
Johns Hopkins University
Start Date
November 21, 2023
End Date
November 20, 2025
Awarded By
Johns Hopkins University
Start Date
November 21, 2023
End Date
November 20, 2025